NEWS.COM.AU
Earlier this month, the global president of Canadian firm Tilray predicted medical marijuana had the potential to be a billion-dollar industry in Australia and create thousands of skilled jobs.
NEWS.COM.AU
Earlier this month, the global president of Canadian firm Tilray predicted medical marijuana had the potential to be a billion-dollar industry in Australia and create thousands of skilled jobs.
ABC NEWS AUSTRALIA
Medical cannabis is a US$10b market that will grow to $100b over next 3 to 5 years, that's according to Brendan Kennedy, global president of Tilray, one of the largest producers of the product. Tilray is owned by US private equity firm Privateer Holdings. Last week the Australian senate passed legislation to allow the growing of medical cannabis.
AUSTRALIAN BROADCASTING CORPORATION
The largest clinical trial of its kind, testing medicinal cannabis to treat chemotherapy patients suffering from nausea, has been announced by New South Wales Premier Mike Baird. About 330 patients are expected to take part in the clinical trial which will use a cannabis-derived tablet manufactured by Canadian company Tilray.
SYDNEY MORNING HERALD
A Canadian pharmaceutical company, Tilray, will supply the trial with specially-prepared tablets that contain marijuana extracts that maximise the drug's anti-nausea properties and minimise its psychoactive effects.